Add this topic to your myFT Digest for news straight to your inbox
Demystifying the purple haze at the Canadian pot producer.
Buyers of marijuana shares should be wary of the hype around legalised pot
Synthetic cannabinoids Spice and K2 are particularly dangerous, British Science Festival hears
A documentary investigates Latin America’s most notorious narcotics barons and hitmen
As production moves to the developed world, policymakers are struggling to keep up
Regulation of illicit industry for medicinal use seen as a solution to trade deficit
Big Tobacco offers a cheaper and safer way into the psychoactive drug
The issue of legalisation has split Democrats and the civil rights movement in the US state
The UK government favours prohibition, but its approach is not working
Former Bear Stearns broker sets up legal cannabis industry networking business
There are still questions about medical benefits, safety and social acceptability
The Commonwealth Bank of Australia allowed cash deposits without legal safeguards
Legal uncertainty limits financial options for suppliers and retailers
Grower Aphria to take control of processing specialist Nuuvera
Aurora bags rival CanniMed to establish ‘best-in-class’ company ahead of legalisation
Helen Clark, child mortality, smartphone addiction
Stocks took a hit but investors will not allow the DoJ to harsh their buzz
‘Return to the rule of law’ as administration heads on collision course with states
Decision to legalise cannabis for export boosts industry
As the state prepares to fully legalise marijuana, established players are wary of new generation of start-ups
The country has done much but region’s leaders must also act, says prime minister
Casa Verde’s Karan Wadhera says none of its investments touch the plant itself
Dramatic surge in cultivation angers Trump administration keen to tackle drug abuse
Society’s muddled thinking on its causes and cures harms individuals and families
Converted army facility in Wiltshire used to grow drugs on an ‘industrial scale’
